In the manufacturers STEP clinical trial program for the branded product Wegovy, adults without diabetes lost on average about 15 percent of their body weight over 68 weeks when semaglutide was combined with lifestyle changes, according to the FDA Wegovy prescribing information and the New England Journal of Medicine STEP 1 trial results
At Centra Internal Medicine, we follow FDA guidelines to determine eligibility
Your doctor will consider your complete medical history, current thyroid function, diabetes control, and treatment goals when determining the optimal approach for your treatment
A dedicated Care Coach for support throughout your journey with Get Thin MD
This release was published on openPR
Start by taking a low dose for a few weeks, and then gradually increase it while maintaining a high fluid intake